Gabapentin
Product Images NDC 51407-049

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 51407-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407 047 90lb Gabapentin 100 mg Capsules Rev Nov 2020 Pmg Nov 2020 12 17 2020

This is a description of Gabapentin capsules with NDC code 51407-047-90. The capsules contain 100 mg of Gabapentin and come in a bottle of 90 capsules. Dosage instructions are provided in the package insert. The storage temperature range is between 20-28°C (68-82°F).*

FDA Label Image

51407 048 90lb Gabapentin 300 mg Capsules Rev Nov 2020 Pmg Nov 2020 12 31 2020

This is a description of gabapentin capsules, USP. Each capsule contains 300mg of gabapentin. The package includes 90 capsules and a Sese insert for dosage information. This medication should be kept out of reach of children and stored in a cool and dry place. The capsules are manufactured by Scleden Pharmaceuticals and packaged by GBMS, and are intended for distribution and dispensing to patients.*

FDA Label Image

51407 049 90lb Gabapentin 400 mg Capsules Rev Nov 2020 Pmg Nov 2020 12 17 2020

FDA Label Image

Figure 1 (Image 01)

This appears to be a table or chart with some numerical values related to pain scores and medication dosage. It is unclear what the context or purpose of this information is without further information.*

FDA Label Image

Figure 2 (Image 02)

This text describes a graph with a 4-week fixed dose period for Gabapentin and a placebo. The weeks are shown along the horizontal axis and the mean pain scores are shown along the vertical axis. The Gabapentin is administered at two different dosages, 1800mg/day and 2400mg/day. The graph shows the changes in mean pain scores over the 4-week period.*

FDA Label Image

Figure 3 (Image 03)

FDA Label Image

Cockcroft And Gault Equation (Image 04)

FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Image 09)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.